MRSA (CA-. MRSA), and streptococci. Coverage for gram negative organisms is clindamycin, change clindamycin to alternate active agent such as bactrim or.
these 2 antibiotics for the treatment of a CA-MRSA skin infection. The patients with clindamycin-resistant MRSA received clindamycin as their
clindamycin. [ CLOSE WINDOW ]. Clues to Inducible Clindamycin Resistance in MRSA. Slide 21. Clues to Inducible Clindamycin Resistance in MRSA. (Enlarge Slide).
MRSA (CA-. MRSA), and streptococci. Coverage for gram negative organisms is clindamycin, change clindamycin to alternate active agent such as bactrim or.
Clindamycin or Ampicillin/ sulbactam. Clindamycin. Tonsillectomy. Not and no MRSA screen (but history of MRSA infection/ colonization). Cefazolin
Recent MRSA infection. Known MRSA ± Clindamycin 600mg IV Q8H. (use in combination /- Vancomycin Loading Dose (existing EPIC entry)
If MRSA clindamycin susceptible: Clindamycin. 10mg/kg/dose PO q8h (max dose: 450mg). If low suspicion for MRSA or. MRSA PCR negative or MSSA.
Clindamycin (see dosing in oral switch box below). If not resolving and MRSA Clindamycin 300mg tds 50kg. Clindamycin 450mg tds kg.
Our findings support age-based dosing. Keywords. MRSA; population pharmacokinetics; clindamycin; pediatrics. Clindamycin is a lincosamide
Comments